Benzinga's Top Pre-Market NASDAQ Gainers (SNTS, LLNW, APWR, MNKD)

Santarus Inc SNTS rose 15.00% to $3.22 in the pre-market session. SNTS announced favorable results for its drug budesonide MMX, for ulcerative colitis treatment, in a late-stage trial. Limelight Networks Inc LLNW added 12.12% to $6.20 in the pre-market session. LLNW quarterly revenue soared 30.50% y/y. A-Power Energy Generation Systems Ltd APWR soared 7.65% to $8.16 in the pre-market trading. APWR entered a three-phase, six-year RMB 1.87 billion ($279 million) EPC contract with Baishan Long Run Water Conservancy Development Co Ltd. MannKind Corp MNKD moved up 4.86% to $6.90 in the pre-market session. Rumors are that Eli Lilly & Co LLY could be interested in buying MNKD for $12.50 per share. Read more from Benzinga's Markets.